- Show All
- Regulatory & Lesgislative Comment
- Publications
- DiMe Blog
- Multimedia
-
2020-2025 Federal Health IT Strategic Plan
The Department of Health and Human Services, led by the Office of the National Coordinator for Health Information Technology (ONC), released the draft 2020-2025 Federal Health IT Strategic Plan (plan) for public comment.
March 31, 2020
Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials
With contribution from our DIMe leadership, this report provides a considered approach tocompiling a comprehensive body of evidence to justify acceptance of mobile sensors for support of new drugapplications
April 2020 in Contemporary Clinical Trials
Patient-Focused Drug Development Guidance: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision Making
The FDA hosted a public workshop to convene a discussion on incorporating clinical outcome assessments (COAs) into endpoints for regulatory decision making. There was a subsequent comment period.
February 4, 2020
Knowledge Sharing at Lightning Speed: Introducing DiMe’s New Forum for Rapid Collaboration
DiMe hosted our first community-driven presentation series: "Lightning Speed Crowdsourcing"
January 31, 2020 in DiMe Blog
Advancing Digital Medicine to Optimize Human Health: 2019 in Review
DiMe’s first year-end report card highlights seven months of growth, collaboration, and awareness
December 31, 2019 in DiMe Blog
How Can Digital Data and Technologies Improve Health?
DiMe submitted a letter in response to the request for input on the initial vision for Cures 2.0; suggestions for Cures 2.0 highlighted the capabilities of digital data and technologies
December 18, 2019 in DiMe Blog
Congress seeks input on Cures 2.0
U.S. Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) released their initial vision for their landmark Cures 2.0 legislation and called on experts and stakeholders to submit their ideas and feedback on the plan.
December 16, 2019
Digital Medicine 101
Amazon Web Services (AWS) and DiMe partner up to discuss innovation and advancements in biomedical research and patient care using digital medicine tools.
December 12, on FiercePharma
People Always, Patients Sometimes
Janet Kennedy interviews DiMe Executive Director Jen Goldsack to discuss the digitalization and democratization of medicine.
December 2, on SpencerHealth Solutions
mHealth and patient generated health data: stakeholder perspectives on opportunities and barriers for transforming healthcare
DiMe member Debbe McCall co-authored this article on the collection of patient-generated health data and its potential impact on efficient care.
September 20, 2019 in mHealth
Former Olympian Champions Digital Health
Kevin Edwards interviews DiMe Executive Director, Jen Goldsack for the Real Leaders podcast during the 2019 Exponential Medicine Conference
November 11, on RealLeaders
Digital Health, Digital Medicine, Digital Therapeutics (DTx): What’s the difference?
This blog post is co-authored by experts from DiMe, the Digital Therapeutics Alliance, HealthXL, and NODE.Health. It describes our proposed framework for categorizing the digital health industry.
November 10, 2019 in DiMe Blog
Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative
Many DiMe members contributed to the Clinical Trials Transformation Initiative (CTTI) recommendations published here.
November 6, 2019 in Digital Biomarkers
Digital endpoints library can aid clinical trials for new medicines
DiMe leadership describe the importance of our library of digital endpoints in this STAT News First Opinion piece.
Novemer 6, 2019 in Stat News
The Digital Medicine Society (DiMe): advancing the use of digital medicine to optimize health
During the 2019 CNS Summit DiMe leadership presented a poster on our work to advance the field of digital medicine
October 31, 2019 in Innovations in Clinical Neuroscience
What it Takes to Lead in the New Field of Digital Medicine: Being Terrified, Apparently…
In this DiMe blog post, Executive Director Jen Goldsack reflects on her experience submitting DiMe's first public comment to FDA.
September 30, 2019 in DiMe Blog
21st Century Cures: Establishment of the BEST Resource Taxonomy
The FDA established a public docket to receive comments from interested parties on the Agency's publication of a glossary of terms which is part of the BEST (Biomarkers, EndpointS, and other Tools) Resource Taxonomy.
September 23, 2019
Digital Medicine Standards 101
In this guest authored DiMe blog, Christine Manta cuts through the noise around standards in digital medicine to summarize the information we all must know.
September 12, 2019 in DiMe Blog
DiMe at DEF CON 27: What We Can Learn from the Security Research Community
A review of DiMe's participation in the Biohacking Village at DEF CON, 2019, the case for prioritizing security research, and DiMe wins an award!
August 14, 2019 in DiMe Blog
Lessons Learned Implementing Apple ResearchKit for a Study at Mount Sinai
In our first guest authored DiMe blog, Noah Zimmerman shares his experience with Apple Research Kit
August 5, 2019 in DiMe Blog
Mind the Gap: The Ethics Void Created by the Rise of Citizen Science in Health and Biomedical Research
DiMe SLB member, Bray Patrick-Lake, and Jennifer Goldsack contributed this editorial to a special issue on citizen science.
July 24, 2019 in The American Journal of Bioethics
Let's Talk About DiMe - A New Society of Digital Medicine Professionals!
Host Erin Albert interviews executive director Jen Goldsack about the first few months of DiMe.
July 4, 2019 | The Dr. Erin L Albert Podcast
Invisible work and changing roles: Health information technology implementation and reorganization of work practices for the inpatient nursing team
With sociologist Dr. Meredith Bergey, DiMe's Jennifer Goldsack and Edmondo Robinson published qualitative research from the inpatient setting.
June 27, 2019 in Social Science & Medicine
The Digital Medicine Society (DiMe) Manifesto: A Commitment to Achievement
In this DiMe blog post we lay out our manifesto, clearly stating our goals for DiMe.
June 10, 2019 in DiMe Blog
A systematic review of feasibility studies promoting the use of mobile technologies in clinical research
DiMe leadership contributed to this Clinical Trials Transformation Initiative (CTTI) systematic review and living database of feasibility studies of mobile technologies for use in clinical trials.
June 6, 2019 in NPJ Digital Medicine
DiMe: Calling all who serve in digital medicine
In this OpEd Jen Goldsack, Beau Woods and Eric Perakslis describe how DiMe is building a digital medicine community to advance the field for the greatest good.
June 5, 2019 in STAT News
Laying the Foundation: Defining Digital Medicine
Read DiMe’s first official blog post. It lays the foundation for the Society by defining digital medicine.
June 3, 2019 in DiMe Blog
Introducing the Digital Medicine Society (DiMe)
Learn about why DiMe co-founder, Andy Coravos, and Scientific Leadership Board member, Bray Patrick-Lake, believe in an important future for DiMe.
May 29, 2019 in Duke Forge Blog
A New Chapter
Editor-in-Chief of Digital Biomarkers, and member of the DiMe Scientific Leadership Board, highlights the role we all can play in realizing the potential of digital tools to improve health.
May 20, 2019 in Digital Biomarkers
Tech world and medicine come together to harness digital medicine
Members of DiMe's Strategic Advisory Board and Scientific Leadership board describe the evolving field of digital medicine and reflect on the role of supporting organizations.
May 17, 2019 in Maturitas
Digital Medicine: A Primer on Measurement
DiMe’s first publication provides a brief introduction to the core concepts and terms that define digital medicine.
May 10, 2019 in Digital Biomarkers
Advancing Digital Medicine: Stronger, Smarter and Faster
Host Dan Kendall interviews DiMe Executive Director, Jennifer Goldsack, about the new Society
May 13, 2019 | Digital Health Today Podcast